Swiss National Bank reduced its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 683,600 shares of the company's stock after selling 39,200 shares during the period. Swiss National Bank owned approximately 0.28% of Cardinal Health worth $80,849,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of CAH. State Street Corp grew its position in Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the period. Geode Capital Management LLC grew its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock worth $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Cardinal Health by 4.7% during the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock worth $474,203,000 after purchasing an additional 191,568 shares in the last quarter. Amundi lifted its holdings in Cardinal Health by 5.5% during the 4th quarter. Amundi now owns 2,116,291 shares of the company's stock valued at $259,309,000 after purchasing an additional 110,605 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Cardinal Health by 3.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company's stock valued at $179,653,000 after buying an additional 44,386 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
CAH has been the subject of a number of research analyst reports. Evercore ISI upgraded shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a research note on Tuesday, January 7th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Finally, Wells Fargo & Company boosted their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $139.36.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Price Performance
Shares of CAH traded up $0.63 during mid-day trading on Wednesday, hitting $132.09. 1,364,395 shares of the company's stock were exchanged, compared to its average volume of 1,967,222. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $133.12. The company has a market cap of $31.91 billion, a PE ratio of 24.64, a P/E/G ratio of 1.49 and a beta of 0.66. The company has a 50-day simple moving average of $126.75 and a 200 day simple moving average of $119.69.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.53%. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.